Shanghai Henlius Biotech, Inc. (HKG:2696)

Shanghai Henlius Biotech Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	34,512	12,881	7,555	6,957	11,984	25,517
Market Cap Growth	70.50%	70.50%	8.59%	-41.95%	-53.03%	15.21%
Enterprise Value	37,528	16,522	11,112	10,233	13,635	25,011
Last Close Price	63.50	23.70	13.90	12.80	22.05	46.95
PE Ratio	39.53	14.75	12.56	-	-	-
Forward PE	34.16	15.91	12.55	-	-	-
PS Ratio	5.67	2.11	1.27	1.91	5.80	36.57
PB Ratio	10.76	4.02	3.13	3.76	4.25	6.72
P/TBV Ratio	-	-	-	-	25.87	12.46
P/FCF Ratio	30.09	11.23	11.94	15.51	-	-
P/OCF Ratio	26.11	9.75	6.54	6.27	108.01	-
EV/Sales Ratio	6.16	2.71	1.87	2.82	6.60	35.84
EV/EBITDA Ratio	28.58	13.36	10.82	-	-	-
EV/EBIT Ratio	40.70	17.92	15.45	-	-	-
EV/FCF Ratio	32.72	14.40	17.57	22.82	-	-
Debt / Equity Ratio	1.21	1.21	1.87	2.25	1.14	0.57
Debt / EBITDA Ratio	2.96	2.96	4.07	-	-	-
Debt / FCF Ratio	3.39	3.39	7.13	9.27	-	-
Asset Turnover	0.56	0.56	0.57	0.40	0.25	0.10
Inventory Turnover	2.07	2.07	1.95	1.44	1.44	0.84
Quick Ratio	0.34	0.34	0.34	0.27	0.35	0.67
Current Ratio	0.50	0.50	0.53	0.44	0.56	0.97
Return on Equity (ROE)	31.52%	31.52%	28.52%	-35.35%	-35.81%	-27.60%
Return on Assets (ROA)	5.28%	5.28%	4.33%	-4.88%	-6.11%	-9.37%
Return on Capital (ROIC)	8.37%	8.37%	7.04%	-7.68%	-8.36%	-11.99%
Return on Capital Employed (ROCE)	15.60%	15.60%	13.50%	-	-	-
Earnings Yield	2.53%	6.78%	7.96%	-11.30%	-10.08%	-4.62%
FCF Yield	3.32%	8.91%	8.37%	6.45%	-3.79%	-5.43%
Buyback Yield / Dilution	-0.02%	-0.02%	-0.25%	-0.59%	-1.75%	-6.52%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.